Drug Shortage Report for XERESE

Last updated on 2018-02-13 History
Report ID 23233
Drug Identification Number 02404044
Brand name XERESE
Common or Proper name XERESE
Company Name VALEANT CANADA LP/VALEANT CANADA S.E.C.
Market Status MARKETED
Active Ingredient(s) ACYCLOVIR HYDROCORTISONE
Strength(s) 5% 1%
Dosage form(s) CREAM
Route of administration TOPICAL
Packaging size n/a
ATC code D06BB
ATC description CHEMOTHERAPEUTICS FOR TOPICAL USE
Reason for shortage Other (Please describe in comments)
Anticipated start date 2017-10-31
Actual start date
Estimated end date 2018-02-28
Actual end date 2018-02-12
Shortage status Resolved
Updated date 2018-02-13
Company comments
Health Canada comments
Contact Address 2150 BOUL. ST-ELZEAR OUEST
LAVAL, QUEBEC
CANADA H7L 4A8
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v10 2018-02-13 English Compare
v9 2018-02-12 French Compare
v8 2018-02-12 English Compare
v7 2018-01-23 French Compare
v6 2018-01-23 English Compare
v5 2017-11-01 English Compare
v4 2017-09-25 French Compare
v3 2017-09-25 English Compare
v2 2017-09-25 French Compare
v1 2017-09-25 English Compare